Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Canine CRISPR trial raises hopes for humans with deadly disease

Restoration of dystrophin in diaphragm treated with CRISPR

Muscle from a healthy dog (left panel) includes the protein dystrophin (green); this is missing (centre) in tissue from a dog with a muscle-wasting disease but can be restored (right) by a gene-editing regimen. Credit: UT Southwestern

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 561, 9 (2018)




Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links